Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Metastasis02:30

Metastasis

6.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.7K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

6.2K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.2K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Cediranib with weekly paclitaxel or olaparib versus weekly paclitaxel for advanced or recurrent endometrial cancer (COPELIA): a multicentre, open-label, randomised, phase 2 trial in the UK.

EClinicalMedicine·2026
Same author

Advancing the applications of liquid biopsies in oncology.

Nature reviews. Genetics·2026
Same author

Use of circulating tumour DNA to prospectively guide a switch from targeted to immune therapy in BRAF mutant advanced melanoma: the randomised phase II CAcTUS trial.

Nature communications·2026
Same author

Cell-free DNA methylome and fragmentome analysis for relapse monitoring of Ewing sarcoma.

EMBO molecular medicine·2026
Same author

Abrogation of Oncogenic RAS Signaling by a RAS(ON) Inhibitor Doublet Primes Immune-Refractory KRASG12C-Mutant NSCLC for Immune Checkpoint Blockade.

Cancer discovery·2026
Same author

Expression of Concern: Application of Sequencing, Liquid Biopsies, and Patient-Derived Xenografts for Personalized Medicine in Melanoma.

Cancer discovery·2026

関連する実験動画

Updated: Mar 5, 2026

Rapid Isolation of Viable Circulating Tumor Cells from Patient Blood Samples
07:32

Rapid Isolation of Viable Circulating Tumor Cells from Patient Blood Samples

Published on: June 15, 2012

27.3K

スナップショット: 循環する腫瘍細胞

Caroline Dive, Ged Brady

    Cell
    |March 25, 2017
    PubMed
    まとめ

    No abstract available in PubMed .

    さらに関連する動画

    Capture and Release of Viable Circulating Tumor Cells from Blood
    08:10

    Capture and Release of Viable Circulating Tumor Cells from Blood

    Published on: October 28, 2016

    9.0K
    Circulating Tumor Cell Lines: an Innovative Tool for Fundamental and Translational Research
    07:47

    Circulating Tumor Cell Lines: an Innovative Tool for Fundamental and Translational Research

    Published on: December 25, 2021

    4.7K

    関連する実験動画

    Last Updated: Mar 5, 2026

    Rapid Isolation of Viable Circulating Tumor Cells from Patient Blood Samples
    07:32

    Rapid Isolation of Viable Circulating Tumor Cells from Patient Blood Samples

    Published on: June 15, 2012

    27.3K
    Capture and Release of Viable Circulating Tumor Cells from Blood
    08:10

    Capture and Release of Viable Circulating Tumor Cells from Blood

    Published on: October 28, 2016

    9.0K
    Circulating Tumor Cell Lines: an Innovative Tool for Fundamental and Translational Research
    07:47

    Circulating Tumor Cell Lines: an Innovative Tool for Fundamental and Translational Research

    Published on: December 25, 2021

    4.7K